CLS
CELESTICA INC
Technology • CIK: 0001030894
Loading...
Market Cap
$28.48B
P/E (TTM)
39.8x
Rev Growth (TTM)
—
Net Margin (TTM)
6.4%
FCF Yield (TTM)
1.4%
FCF Margin (TTM)
3.5%
Cash Flow Health
Free Cash Flow7/8 positive
TTM$398M
Q3 '25
$89M-26%
Q2 '25
$120M+28%
FCF Margin
TTM3.5%
Q3 '252.8%-33%
Sector: 14.5%Below Avg
OCF Margin4.9%
OCF/NI0.77x
CapEx Coverage3.6x
FCF Yield1.4%
FCF Growth (2Y)–
Cash Conversion Cycle
86 days
DSO: 71+DIO: 68−DPO: 53
Capital Allocation & Returns
Growth Focused
Total Shareholder YieldTTM
TTM0.5%
Div Yield0.0%
+Buyback (TTM)0.5%
Prioritizing reinvestment over distributions
Dividend & Payout Metrics
Dividend Yield (TTM)0.0%
Free Cash Flow (TTM)$398.2M
Stock Repurchases (TTM)$143.2M
Capital Return / FCF36.0%
Est. Dividends Paid (TTM)$0
Shows how management rewards shareholders
Operational Efficiency & Returns
Return on Invested CapitalTTM
33.7%
P25MedianP75
75th pctl (med: 0.1%)
DuPont BreakdownROIC = Margin × Turn × (1+D/E)
NOPAT Margin
6.8%
Asset Turnover
1.85x
Leverage (1+D/E)
1.37x
D/E: 0.37x
DuPont: 17.2% ≈ 33.7% ROIC
Asset & CapEx Efficiency
Fixed Asset Turn
20.82x
8Q:–
Invested Cap Turn
4.98x
8Q:–
CapEx Intensity
6.8%
8Q:–
CapEx/Depreciation
0.95x
Asset-based ROIC formula
QUARTERLY TRENDS
Last 7 quarters + TTM
| Metric | TTM | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|
Revenue | $11.3B | $3.2B↑10.4% | $2.9B↑9.2% | $2.6B↑4.0% | $2.5B↑1.8% | $2.5B↑4.5% | $2.4B↑8.3% | $2.2B |
Operating Income | $928.9M | $325.0M↑19.3% | $272.5M↑111.6% | $128.8M↓36.4% | $202.6M↑46.8% | $138.0M↑3.8% | $132.9M↑5.6% | $125.8M |
Net Income | $716.7M | $267.8M↑26.9% | $211.0M↑144.8% | $86.2M↓43.2% | $151.7M↑69.5% | $89.5M↓5.8% | $95.0M↑3.5% | $91.8M |
Operating Cash Flow | $552.3M | $126.2M↓17.2% | $152.4M↑17.0% | $130.3M↓9.1% | $143.4M↑16.8% | $122.8M↑23.3% | $99.6M↓7.9% | $108.1M |
Free Cash Flow | $398.2M | $88.9M↓25.9% | $119.9M↑28.1% | $93.6M↓2.3% | $95.8M↑24.7% | $76.8M↑22.5% | $62.7M↓7.4% | $67.7M |
Total Equity | N/A |
Valuation Analysis
Fair Value
Price-to-EarningsTTM
39.8x
Valuation Lenses
Earnings
39.8x
vs – sector
Cash Flow
1.2x
EV/FCF vs –
Growth-Adj
–PEG
N/A
Quality-Adj
1.2P/E per %ROIC
ROIC: 33.7%
Shareholder Returns
Dividend
–
Buyback
0.5%
Total Yield
0.5%
Market Cap$28.48B
EV–
Multi-angle valuation analysis with sector context
Business Quality & Moat
Overall Quality Score
90/100
Exceptional
Composite score: Returns (40%) + Consistency (30%) + Earnings Quality (30%)
Returns on Capital
Return on Equity (ROE)Top 10%
40.0%
8Q:–
Return on Invested Capital (ROIC)Top 25%
33.7%
8Q:–
vs Sector:0.1%
DuPont Analysis (ROIC = NOPAT Margin × Asset Turnover)
NOPAT Margin: 6.8%
Asset Turnover: 1.85x
Earnings Quality
Cash Conversion
0.77x
OCF / Net Income
FCF Consistency
–
Positive quarters
Competitive Moat Indicators
Pricing Power
Gross Margin12.0%
Capital Efficiency
Invested Capital Turnover4.98x
Working Capital
Cash Conversion Cycle86 days
Growth Quality & Momentum
Growth Rates
Revenue Growth YoY
N/A
OpInc Growth YoY
135.5%
EPS Growth YoY
N/A
FCF 3Y CAGR
N/A
Margin Quality & Sustainability
Low Quality
Profitability Cascade
Gross
12.0%
Operating
8.2%
Below Avg in sector
Net
6.4%
Margins Unknown
Earnings Quality Signals
SBC / Revenue
—
FCF vs Net Gap
-2.8 pts
FCF: 3.5% | Net: 6.4%
Quality = stability + cash conversion + low dilution
Balance Sheet & Solvency
Adequate
Net Debt / EBITDA
–Net Debt: $450.80M
Interest Coverage
–
Leverage Metrics
Debt-to-Equity
0.37x
Balance sheet risk & solvency analysis